Two Onc Docs Metastatic Non-Small Cell Lung Cancer
Sep 12, 2022
Exploring the evolving treatment options for metastatic non-small cell lung cancer, including traditional chemotherapy, immunotherapy, and targeted agents. Discussing the significance of targeted medications like EGFR, ALK, and ROS1 inhibitors. Emphasizing the importance of genetic mutation-based sequencing and tailored drug regimens based on PDL1 status.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
Navigating Therapy Options and Targeted Medications in Metastatic Non-Small Cell Lung Cancer
03:07 • 3min
Exploring Targeted Therapies for Metastatic Lung Cancer
05:50 • 2min
Targetable Mutations and Immunotherapy in Metastatic Non-Small Cell Lung Cancer
08:04 • 3min
Treatment Strategies and Key Takeaways for Metastatic Non-Small Cell Lung Cancer
11:30 • 2min